CHRS — Coherus Oncology, Inc.
NASDAQ · Healthcare · Biotechnology
Company fundamentals
| Metric | Cached value |
|---|---|
| Price (USD) | 0.99 |
| Market cap (USD) | 152,955,950 |
| P/E | 4.2 |
| ROE (%) | -800 |
| Net profit margin (%) | 67.32 |
| Revenue growth (%) | 3.78 |
| Dividend yield (%) | 0 |
Price last refreshed: .
Prices refreshed every 5 minutes during US market hours. Individual quotes may be older when provider data is missing or a refresh is incomplete. Check each quote's timestamp.
About Coherus Oncology, Inc.
Available company fundamentals for CHRS in Biotechnology. Values reflect cached source data, not live executable quotes. Valory Formula, when available, is informational analysis, not investment advice.